Actively Recruiting

Age: 18Years +
All Genders
ID04491292

Psychosocial Impact of COVID-19 Pandemic on MD Anderson Workforce

Led by M.D. Anderson Cancer Center · Updated on 2026-01-28

20000

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

M

M.D. Anderson Cancer Center

Lead Sponsor

N

National Cancer Institute (NCI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research aims to understand how the COVID-19 pandemic affects the mental and emotional well-being of employees at MD Anderson Cancer Center. It focuses on measuring psychosocial stress and related outcomes during and after the pandemic to identify factors influencing these effects among medical staff in a high-risk environment. Participants are asked to complete two online questionnaires, each taking about 10 minutes. These surveys are done once at the start of the study and again three months after the pandemic ends to capture changes over time in stress and psychosocial health. During the study, researchers will analyze the questionnaire responses to track changes in psychosocial and stress-related outcomes from baseline through three months after the pandemic. They will also explore how demographic and job-related factors relate to these outcomes. Participation involves minimal time commitment and is fully conducted online, with no additional procedures or visits.

CONDITIONS

Brief Title

Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Currently employed by MD Anderson Cancer Center
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 online screening questionnaire

Monitoring

Duration - Up to 3 months after the pandemic ends

Participants complete questionnaires to assess psychosocial and stress-related outcomes during and after the COVID-19 pandemic.

2 online questionnaires: one at baseline and one at 3 months after the pandemic ends

Trial Site Locations

Total: 1 location

1

M D Anderson Cancer Center

Houston, Texas, United States, 77030

Actively Recruiting

Loading map...

Research Team

P

Priya R. Bhosale

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

A Phase 1, Open-Label, Randomized, Single-Dose, 4-Period Cro...

Coronavirus Disease 2019

Actively Recruiting

1 location

Study of Ibuzatrelvir Alone and With Remdesivir for Symptoma...

COVID-19 Infection

Actively Recruiting

141 locations

A Phase 2 Trial to Evaluate Safety and Immunogenicity of a N...

COVID-19 Infection

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here